The extensive literature on the PDE4/cAMP/PKA pathways and in vitro/in vivo studies on other PDE4 inhibitor molecules further support the potential cardiovascular role of the PDE4 pathway, including its modulation of cardiac hypertrophy and arrhythmogenesis. Here, PDE4A is linked to cardiac hypertrophy.